Loading clinical trials...
Loading clinical trials...
The primary objective of the study is to find the gene(s) responsible for causing DDH. The secondary objective of the study is to determine the mode of genetic transmission of DDH.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
University of Utah
NCT06519955 · Hip Dysplasia
NCT04795843 · Hip Dysplasia
NCT05361980 · Fracture, Lengthening; Leg, and more
NCT06189781 · Cerebral Palsy, Hip Dysplasia, and more
NCT03372278 · Rheumatoid Arthritis With Adequate Bone Quality, Inflammatory Arthritis, and more
University of Utah Orthopaedic Center
Salt Lake City, Utah
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions